Workshop IV: Drug treatment guidelines for the long-term management of Parkinson's disease

Journal of Neurology, Supplement

Volumn 247, Issue 4, 2000, Pages 40-41

  Reichmann, H ^a   Sommer, U ^a   Fuchs, G ^a   Hefter, H ^a   Mark, G ^a   Muller, T ^a   Thumler, R ^a   Ulm, G ^a   Vieregge, P ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Guidelines; Parkinson's disease; Treatment

Indexed keywords

AMANTADINE; BUDIPINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR ANTAGONIST; LEVODOPA; SELEGILINE;

AKINESIA; ALGORITHM; CLINICAL PROTOCOL; CONFERENCE PAPER; DRUG EFFECT; DRUG INDICATION; HUMAN; LONG TERM CARE; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; TREMOR;

ADULT; AGE FACTORS; AGED; DISEASE PROGRESSION; EDUCATION; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PRACTICE GUIDELINES;

EID: 0033817374     PISSN: 09391517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)